Top Story

Implantation depth, prosthesis oversizing may predict conduction abnormalities, pacemaker need post-TAVR

February 5, 2016

In patients undergoing transcatheter aortic valve replacement with a next-generation valve, deeper implantation and prosthesis oversizing appear to be associated with a higher rate of new conduction abnormalities or need for permanent pacemaker implantation, according to study findings.

Researchers identified 244 consecutive patients (mean age, 81 years) with a logistic EuroSCORE of 16% who underwent TAVR with the next-generation valve (Sapien 3, Edwards Lifesciences) at Technische Universität München, Munich, Germany. After excluding patients with a previous pacemaker, atypical valvular anatomy and degenerated biological prosthesis, 208 patients were eligible for inclusion. TAVR was performed using the 23-mm Sapien 3 valve in 44% of patients while the 26-mm valve was used in 38% of patients and the 29-mm valve was used in 18% of patients.

ABIM continues to engage physicians on MOC updates

February 5, 2016
The ABIM has announced several new efforts aimed at including internists and subspecialists in the process of improving Maintenance of Certification assessments…

National Wear Red Day increases awareness of women's heart health

February 5, 2016
On Friday, Feb. 5, employees at SLACK Incorporated, publisher of Cardiology Today and Cardiology Today’s Intervention wore red in support of the American Heart…
FDA News

First MR-conditional CRT-D receives FDA approval

February 5, 2016
Medtronic announced that it has received FDA approval for the first MRI-conditional cardiac resynchronization therapy defibrillators for the treatment of HF.The systems…

House committee hearing investigates recent drug price hikes

February 5, 2016
In a recent hearing, members of the House Committee on Oversight and Government Reform questioned representatives from Turing Pharmaceuticals and Valeant Pharmaceuticals…
More News Headlines »